As of 2025-03-22, the Relative Valuation of Teladoc Health Inc (TDOC) is (260.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.41 USD, the upside of Teladoc Health Inc based on Relative Valuation is -3196.8%.
The range of the Relative Valuation is (238.33) - (234.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 41.3x - 54.8x | 50.9x |
| Forward P/E multiples | 32.4x - 40.6x | 39.4x |
| Fair Price | (238.33) - (234.07) | (260.44) |
| Upside | -2933.9% - -2883.2% | -3196.8% |
| Date | P/E |
| 2025-03-21 | -1.46 |
| 2025-03-20 | -1.42 |
| 2025-03-19 | -1.47 |
| 2025-03-18 | -1.46 |
| 2025-03-17 | -1.54 |
| 2025-03-14 | -1.50 |
| 2025-03-13 | -1.47 |
| 2025-03-12 | -1.54 |
| 2025-03-11 | -1.56 |
| 2025-03-10 | -1.55 |
| 2025-03-07 | -1.59 |
| 2025-03-06 | -1.63 |
| 2025-03-05 | -1.57 |
| 2025-03-04 | -1.60 |
| 2025-03-03 | -1.64 |
| 2025-02-28 | -1.66 |
| 2025-02-27 | -1.65 |
| 2025-02-26 | -1.91 |
| 2025-02-25 | -1.94 |
| 2025-02-24 | -1.98 |
| 2025-02-21 | -2.00 |
| 2025-02-20 | -2.20 |
| 2025-02-19 | -2.39 |
| 2025-02-18 | -2.27 |
| 2025-02-14 | -2.49 |
| 2025-02-13 | -2.34 |
| 2025-02-12 | -2.18 |
| 2025-02-11 | -2.26 |
| 2025-02-10 | -2.40 |
| 2025-02-07 | -2.25 |
| 2025-02-06 | -2.08 |
| 2025-02-05 | -1.91 |
| 2025-02-04 | -1.80 |
| 2025-02-03 | -1.74 |
| 2025-01-31 | -1.76 |
| 2025-01-30 | -1.79 |
| 2025-01-29 | -1.80 |
| 2025-01-28 | -1.82 |
| 2025-01-27 | -1.77 |
| 2025-01-24 | -1.75 |
| 2025-01-23 | -1.76 |
| 2025-01-22 | -1.71 |
| 2025-01-21 | -1.65 |
| 2025-01-17 | -1.58 |
| 2025-01-16 | -1.59 |
| 2025-01-15 | -1.62 |
| 2025-01-14 | -1.62 |
| 2025-01-13 | -1.68 |
| 2025-01-10 | -1.71 |
| 2025-01-08 | -1.70 |